Acepodia logo

Acepodia

POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER

49 employees · est. 2016 · Alameda, United States

VS
Link Cell Therapies logo

Link Cell Therapies

A True CAR T Cell AND-Gate

22 employees · est. 2022 · South San Francisco, United...

Acepodia is the older company (2016 vs 2022).

Side-by-Side Comparison

Acepodia Link Cell Therapies
Founded
2016 older 2022
Headquarters
Alameda, United States South San Francisco, United States
Employees
49 22
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Life Sciences
Funding Stage
Series D Not tracked yet
Total Funding
$256.00M Not tracked yet
Funding Rounds
3 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Acepodia, Clinical-stage, Cancer Cell Immunotherapy, Off-the-shelf, NK Cells, Antibody-cell Conjugation, Cell Therapy, Oncology, Immune Effector Cells, Solid Tumors, Hematologic Cancers, Immunotherapeutic Strategies, Interdisciplinary Technology Cell Therapy, Cancer Treatment, Logic-Gate Technology, CAR T Cell Therapy, Oncology, Solid Tumors, Immunotherapy, Precision Medicine, Biomedical Research
Website
acepodia.com linkcelltx.com
Acepodia logo

About Acepodia

Acepodia is a clinical-stage biotechnology company founded in 2016, with a focus on developing innovative and highly effective cell therapies for cancer patients. The company's slogan, "POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER," encapsulates its mission. Acepodia leverages its An...

Link Cell Therapies logo

About Link Cell Therapies

Link Cell Therapies is a biotechnology startup established in 2022 by Stanford founders Robbie Majzner and Crystal Mackall, in collaboration with investors Samsara BioCapital and Sheatree Capital. The company's focal point is the advancement of a cutting-edge logic-gate technology to propel a new er...

We will tell you when either one moves

BounceWatch watches Acepodia and Link Cell Therapies for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Acepodia and Link Cell Therapies — by email.

Frequently Asked Questions

Acepodia — POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER. Link Cell Therapies — A True CAR T Cell AND-Gate. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Acepodia has raised $256.00M while Link Cell Therapies has raised undisclosed funding.
Acepodia and Link Cell Therapies operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Acepodia with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Acepodia on 11 Sep 2024, and Link Cell Therapies on 16 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy